Published in Lipid Insights on November 11, 2008
Protein tyrosine nitration in cellular signal transduction pathways. J Recept Signal Transduct Res (2010) 0.85
Factors influencing protein tyrosine nitration--structure-based predictive models. Free Radic Biol Med (2010) 0.80
A combination of palm oil tocotrienols and citrus peel polymethoxylated flavones does not influence elevated LDL cholesterol and high-sensitivity C-reactive protein levels. Eur J Clin Nutr (2015) 0.75
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25
Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet (1990) 25.12
Inflammation and atherosclerosis. Circulation (2002) 20.77
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care (1993) 17.66
Nitric oxide and peroxynitrite in health and disease. Physiol Rev (2007) 15.49
Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA (2004) 9.91
Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature (1995) 9.86
Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med (1971) 7.46
Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell (1995) 7.13
Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest (2000) 6.84
Prevalence of conventional risk factors in patients with coronary heart disease. JAMA (2003) 6.84
Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67
Nitric oxide synthases in mammals. Biochem J (1994) 6.50
The reaction of no with superoxide. Free Radic Res Commun (1993) 5.65
Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol (2005) 5.30
Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 5.09
Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci U S A (1998) 4.94
Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest (1993) 4.70
Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler (1994) 4.09
Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest (2004) 3.63
Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. JAMA (2007) 3.48
Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation (2003) 3.42
Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol (1996) 3.31
Enhanced peroxynitrite formation is associated with vascular aging. J Exp Med (2000) 3.09
Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol (1996) 2.95
Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem (1998) 2.92
Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study. JAMA (1995) 2.87
n-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr (1997) 2.71
Ca2+/calmodulin-dependent formation of hydrogen peroxide by brain nitric oxide synthase. Biochem J (1992) 2.68
Translating molecular discoveries into new therapies for atherosclerosis. Nature (2008) 2.67
Higher baseline serum concentrations of vitamin E are associated with lower total and cause-specific mortality in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr (2006) 2.64
Six-year effect of combined vitamin C and E supplementation on atherosclerotic progression: the Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) Study. Circulation (2003) 2.63
Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet (1972) 2.59
Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med (1965) 2.50
Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci U S A (1997) 2.47
Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens (2002) 2.42
The composition of food consumed by Greenland Eskimos. Acta Med Scand (1976) 2.27
Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation (2003) 2.26
Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol (2006) 2.19
Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. JAMA (2003) 2.16
Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem Soc Trans (1993) 2.10
Polyunsaturated fatty acids, inflammation, and immunity. Lipids (2001) 2.08
Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels (1991) 1.98
Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem (1998) 1.95
Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett (1996) 1.87
Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest (1998) 1.85
3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method. Biochem J (1998) 1.83
Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun (1997) 1.76
Atherosclerosis: its cause and its prevention. Am J Cardiol (2006) 1.75
Structure-function aspects in the nitric oxide synthases. Annu Rev Pharmacol Toxicol (1997) 1.74
Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J Biol Chem (1997) 1.71
Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem (2004) 1.68
n-3 fatty acids and cardiovascular disease. Am J Clin Nutr (2006) 1.68
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation (2001) 1.63
Formation of nitric oxide-derived oxidants by myeloperoxidase in monocytes: pathways for monocyte-mediated protein nitration and lipid peroxidation In vivo. Circ Res (1999) 1.54
Proteolytic degradation of tyrosine nitrated proteins. Arch Biochem Biophys (2000) 1.49
Nitrotyrosine as a new marker for endogenous nitrosation and nitration of proteins. Food Chem Toxicol (1990) 1.49
Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res (2007) 1.48
Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice. J Immunol (2000) 1.43
Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem (1999) 1.41
Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. Proc Natl Acad Sci U S A (1996) 1.40
Rapid and selective oxygen-regulated protein tyrosine denitration and nitration in mitochondria. J Biol Chem (2004) 1.37
Tyrosine nitration as a mechanism of selective inactivation of prostacyclin synthase by peroxynitrite. Biol Chem (1997) 1.36
Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species. J Biol Chem (2003) 1.36
Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest (1996) 1.35
IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol (2004) 1.35
Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol (1999) 1.31
Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett (1993) 1.27
Hemodynamics influences vascular peroxynitrite formation: Implication for low-density lipoprotein apo-B-100 nitration. Free Radic Biol Med (2006) 1.25
Nitrated and oxidized plasma proteins in smokers and lung cancer patients. Cancer Res (2001) 1.21
Histone H1.2 is a substrate for denitrase, an activity that reduces nitrotyrosine immunoreactivity in proteins. Proc Natl Acad Sci U S A (2003) 1.20
Increased nitration of sarcoplasmic reticulum Ca2+-ATPase in human heart failure. Circulation (2005) 1.19
Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure. Cardiovasc Res (2001) 1.15
Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol (2002) 1.14
Vitamin E intake and risk of amyotrophic lateral sclerosis. Ann Neurol (2005) 1.11
Neuronal NOS-cGMP-dependent ACh-induced relaxation in pial arterioles of endothelial NOS knockout mice. Am J Physiol (1998) 1.11
Antioxidant improves smooth muscle sarco/endoplasmic reticulum Ca(2+)-ATPase function and lowers tyrosine nitration in hypercholesterolemia and improves nitric oxide-induced relaxation. Circ Res (2002) 1.10
Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit. Cardiovasc Drugs Ther (2008) 1.08
Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr (1997) 1.08
Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA (1999) 1.00
Increased protein nitration burden in the atherosclerotic lesions and plasma of apolipoprotein A-I deficient mice. Circ Res (2007) 0.98
Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem (2003) 0.97
Peroxynitrite-induced alpha-actinin nitration and contractile alterations in isolated human myocardial cells. Cardiovasc Res (2005) 0.96
Oxidant stress and atherosclerosis. Curr Opin Pharmacol (2004) 0.95
The treatment of angina pectoris with a nitroglycerin ointment. Am J Med Sci (1955) 0.95
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res (2006) 0.95
n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans. Am J Clin Nutr (1997) 0.95
Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase. Am J Physiol Heart Circ Physiol (2007) 0.94
Identification of immunoglobulins that recognize 3-nitrotyrosine in patients with acute lung injury after major trauma. Am J Respir Cell Mol Biol (2006) 0.92
HMG-CoA reductase inhibitors. Adv Protein Chem (2001) 0.90
Effects of rosuvastatin on 3-nitrotyrosine and aortic stiffness in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2006) 0.90
Vitamin E revisited: do new data validate benefits for chronic disease prevention? Curr Opin Lipidol (2008) 0.89
Involvement of the mitogen-activated protein kinase cascade in peroxynitrite-mediated arachidonic acid release in vascular smooth muscle cells. Am J Physiol Cell Physiol (2004) 0.87
Autocatalytic tyrosine nitration of prostaglandin endoperoxide synthase-2 in LPS-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2006) 0.87
Regulation of prostaglandin H2 synthase activity by nitrogen oxides. Biochemistry (1999) 0.87
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat (2006) 0.84
Inducible nitric oxide synthase gene deletion exaggerates MAPK-mediated cyclooxygenase-2 induction by inflammatory stimuli. Am J Physiol Heart Circ Physiol (2010) 1.46
Heme catalyzes tyrosine 385 nitration and inactivation of prostaglandin H2 synthase-1 by peroxynitrite. J Lipid Res (2006) 0.95
Inducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid production. Am J Pathol (2006) 0.86
Tyrosine nitration in prostaglandin H(2) synthase. J Lipid Res (2002) 0.83
Micro ATR-FTIR spectroscopic imaging of atherosclerosis: an investigation of the contribution of inducible nitric oxide synthase to lesion composition in ApoE-null mice. Analyst (2009) 0.82
Maintaining equilibrium by selective targeting of cyclooxygenase pathways: promising offensives against vascular injury. Hypertension (2007) 0.80
Physical evidence for substrate binding in preventing cyclooxygenase inactivation under nitrative stress. J Am Chem Soc (2010) 0.80
Complex "cross talk" involving nitric oxide metabolites: who's listening? Curr Atheroscler Rep (2006) 0.76